Clinical Trial Update: A Feasibility Study to Assess Tenofovir and Maraviroc Protection Against HIV-1 in Cervical and Vaginal Explants [Phase 1]

View source ↗

Summary

A Phase 1 feasibility study evaluated whether tenofovir and maraviroc can protect against HIV-1 infection in cervical and vaginal explants from healthy adult fe…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Selzentry (Maraviroc) (Maraviroc)
• Viread (Tenofovir disoproxil fumarate) (Tenofovir disoproxil fumarate)

Snippet

Sponsor: University of North Carolina, Chapel Hill | Conditions: Healthy Adult Females | Phase 1 | Status: COMPLETED